N-0750
- Generic Name
- N-0750
Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy
Phase 3
Not yet recruiting
- Conditions
- Painful Diabetic Peripheral Neuropathy (PDPN)
- Interventions
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Eurofarma Laboratorios S.A.
- Target Recruit Count
- 666
- Registration Number
- NCT06715462
- Locations
- 🇧🇷
Eurofarma Laboratórios S.A, Itapevi, São Paulo, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath